Name of organisation
1) Department/Research groupAarhus University, Dept of Clinical Epidemiology
2) Organisation/affiliationAarhus University / Aarhus University Hospital
Short Name in the inventoryAarhus University Dept. of Clinical Epidemiology
Administrative Contact
Title Professor
Last name Ehrenstein
First name Vera
Address line 1Olof Palmes Allé 43-45
Address line 2
Address line 3
CityAarhus N
Postcode8200
CountryDenmark
Phone number (incl. country code)45-87168063
Alternative phone number
Fax number (incl. country code)45-87167215
Scientific Contact
Title Professor
Last name Sørensen
First name Henrik Toft
Address line 1Olof Palmes Allé 43-45
Address line 2
Address line 3
CityAarhus N
Postcode8200
CountryDenmark
Phone number (incl. country code)45-87168063
Alternative phone number
Fax number (incl. country code)45-87167215
Alternative Scientific Contact
Title Professor
Last name Ehrenstein
First name Vera
Address line 1Olof Palmes Alle 43-45
Address line 2
Address line 3
CityAarhus N
Postcode8200
CountryDenmark
Phone number (incl. country code)45-87168063
Alternative phone number
Fax number (incl. country code)45-87167215
2. Description
Department of Clinical Epidemiology is a research department at Aarhus University Hospital and belongs under Institute of Clinical Medicine at Aarhus University. Researchers in the department use modern epidemiological methods to study the prognosis of patient populations. The department is engaged in a great variety of activities regarding research, counselling and improvement of the quality of care and treatment offered to patients. Pharmacoepidemiology is one of the department's research priorities.
3. Category
University based
Hospital based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
Yes
No
Clinician
Yes
Yes
Clinical Pharmacologist
No
Yes
Pharmacist
No
Yes
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
Yes
Ethics expertise
Yes
No
Legal expertise
Yes
Yes
Regulatory expertise
No
Yes
Project management
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Devices
Disorders of the central nervous system
Endocrine disorders
Gastrointestinal tract
Geriatrics
Gynaecology
Immunological products and vaccines
Immunosuppression
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Neonates
Osteoporosis
Paediatrics
Poisoning/Overdose
Pregnancy
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
Vaccines
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
Validation studies
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Less than 150
Between 150 and 1499
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
RedCAP, other
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Danish Registries (access/analysis)300
CPRD3
NorPD10
PHARMO Database Network4
ARS3
11. Registries established by centre
Disease RegistryITP
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
SIGMA
VAC4EU
Other networks:
Network nameNationalInternationalLink to webpage